Press release
Digital Biomarkers Market | 68% hardware dominance, 24.5% CAGR and the companies rewriting clinical measurement
Digital Biomarkers Market | 68% hardware dominance, 24.5% CAGR and the companies rewriting clinical measurement
The Digital Biomarkers Market sits at an intriguing crossroads. The official market number for 2025 - USD 3.0 billion - almost looks conservative when you speak to people close to clinical research. Something bigger is happening underneath that tidy CAGR of 24.5%. We're watching the early formation of a measurement layer that ties consumer-grade wearables, AI-heavy analytics, and hard clinical validation into one ecosystem.
This Black Friday: get 15% off all our market reports.
Buy Now: https://marketgenics.co/buy/digital-biomarkers-market-78664
Call it the new pulse of evidence generation.
Not hype. Not gadgetry. A genuine shift in how medical systems listen to the body.
By 2035, the Digital Biomarkers Market touches USD 33.5 billion. That's the projection. But numbers alone don't capture how quickly digital biomarkers are becoming essential to pharma, neurology clinics, cardiology workflows, insurers, and decentralized trial operators - all of whom need faster, cleaner, more continuous data.
Where the Momentum Actually Comes From
Everyone likes to talk about wearables because they're tangible, but the deeper force lifting this market is structural. Chronic diseases - neurological, cardiovascular, metabolic - need monitoring that goes beyond episodic hospital visits. And digital biomarkers deliver exactly that: subtle, continuous, nearly invisible measurement.
No surprise then that data collection tools control roughly 68% of the Digital Biomarkers Market in 2025. Wearables, mobile apps, ingestible sensors, environmental sensors - all feeding enormous data pipelines.
Take a single example: Fitbit collaborating with medical researchers on real-time cardiovascular and metabolic biomarker tracking. Or Oura teaming up with UC San Diego in early 2025 to validate sleep-driven and activity-based markers for metabolic disorder prediction. These aren't side projects. They are validation exercises that give wearables clinical weight.
Then there's Roche, using digital biomarkers inside oncology and immunotherapy studies - which quietly signals where trials are heading: more personalized, more dynamic, less tethered to traditional endpoints.
Digital Biomarkers in Clinical Trials: The Part That Gets Underestimated
When sponsors talk about Digital Biomarkers in Clinical Trials, there's a subtle shift in tone. Suddenly, continuous gait tracking, sleep irregularity patterns, passive cognitive markers, and micro-changes in motor performance aren't "interesting." They're decision-making tools.
Biogen used smartphone gait measurement in multiple sclerosis trials.
Evidation worked with Eli Lilly to detect early cognitive decline in Alzheimer's.
These are small signals with outsized influence. Individually they look niche; collectively they push the trial model toward something closer to real-world physiology rather than 12-week clinic snapshots.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Digital Biomarkers Market Research Report: https://marketgenics.co/reports/digital-biomarkers-market-78664
Neurology and Cardiology Steal Most of the Attention - and the Budget
Think of the Cardiac Biomarkers Market as running parallel - and increasingly intertwined - with digital biomarkers. Digital tools catch rhythms, micro-arrhythmias, respiratory patterns, and stress fluctuations long before hospital devices intervene.
Neurology is even more dependent on subtlety.
The way someone moves their finger.
The tone of their voice.
Their reaction time.
Their tremor amplitude.
Those small details often scream louder than MRI scans in early-stage disease progression.
MindMaze's 2024 launch of a digital biomarker platform for stroke and Parkinson's patients underscores this. The system uses machine learning to identify faint cognitive and motor shifts - the kind neurologists can't observe during rushed clinical appointments.
ElectronRx's purpleDx app extends something similar to cardiology, pulling heart and lung biomarkers directly from a smartphone - which, a few years ago, would have sounded like science fiction.
What Slows Everything Down | Regulation
Momentum aside, the global rollout moves slower than it should. Regulatory fragmentation acts like a governor on an engine that wants to accelerate.
Verily's Onduo diabetes platform faced scrutiny under EU MDR in 2024 despite strong U.S. performance. Different continents, different standards, different levels of proof required.
When your product relies heavily on wearable data, mobile apps, cloud analytics, and algorithmic interpretation, every regulatory body wants a deeper look. The result is a patchwork of approvals rather than a clean glide path.
This is the bottleneck investors watch most closely.
The Next Layer | Digital Biomarkers Market Inside Digital Therapeutics
Digital therapeutics have been inching their way into mainstream care, but once digital biomarkers were integrated into systems like EndeavorRx, the dynamic changed.
Akili Interactive folded real-time tracking of latency and eye movements into a pediatric ADHD therapy. Suddenly you're not dealing with static software; you're dealing with a therapy that adjusts based on the patient's real physiological response.
Once insurers begin reimbursing these closed-loop systems - therapy in, biomarker out - the Digital Biomarkers Market will gain a completely new demand curve.
To know more about the Digital Biomarkers Market - Download our Sample Report: https://marketgenics.co/download-report-sample/digital-biomarkers-market-78664
Smartphones | The Great Equalizer of Biomarker Access
The humble smartphone is becoming one of the most important biomarker platforms in the world. The sensors, cameras, microphones, accelerometers - all quietly collecting information that, in the right hands, turn into clinically relevant markers.
Koneksa Health's 2024 app is a perfect example: voice tone, facial expression micro-changes, touch interactions - all turned into biomarkers for mental health research.
What this means:
Biomarker collection leaps from specialized hardware to the device people already carry.
Participation scales.
Barriers drop.
Emerging markets get access without infrastructure.
That changes the geometry of the Digital Biomarkers Market more than any single wearable ever will.
North America | The Region Everyone Watches
North America's dominance isn't just a function of money. It's the ecosystem - FDA pathways for breakthrough devices, early academic-industry collaborations, strong biotech funding, and a culture that rewards early pilots.
The FDA granting Breakthrough Device status to NeuroRPM in 2024 - an AI-driven wearable tracking Parkinson's symptoms - shows how quickly the U.S. is willing to support novel endpoints.
Canada follows a similar pattern, especially around decentralized trials and remote patient monitoring.
If you're mapping global expansion, you start here.
Competition | Fragmented but Fiercely Innovative
The Digital Biomarkers Market has more than forty active players, but the shape of competition isn't uniform.
Apple, Google (Fitbit), Empatica, AliveCor, Philips, Evidation - these companies sit at the top with validated ecosystems and trusted data models.
Others like Mindstrong, Koneksa, Neurotrack, and multiple specialized startups dive deeper into niche biomarkers that large vendors don't prioritize.
The most interesting development lately is the tightening relationship between pharma and data companies:
Rune Labs and Parkinson's Foundation (2025): genetics + digital biomarkers in one framework.
VivoSense and argenx (2025): trial efficiency through digital endpoint implementation.
ElectronRx (2025): cardiac biomarkers through smartphones.
This consolidation of data, analytics, and clinical validation will determine who shapes the next decade.
The Digital Biomarkers Market Outlook | USD 30.5 Billion in New Opportunity Between 2025 and 2035
If you remove the noise, one pattern becomes clear: digital biomarkers are entering a phase where they move from "adjacent innovation" to "core infrastructure."
The opportunity window - USD 30.5 billion between 2025 and 2035 - is driven by:
Decentralized clinical trials
AI-driven biomarker interpretation
Chronic disease monitoring
Wearable ecosystem expansion
Smartphone-led biomarker adoption
Insurer appetite for continuous real-world data
A decade from now, nobody will think of digital biomarkers as a separate category. They'll simply be part of how healthcare measures reality.
Request a Tailored Preview (Corporate Buyers & Investors)
If you want the region-level forecasts, therapeutic area splits, vendor benchmarking, pricing analysis, validation timelines, and adoption curves that drive this Digital Biomarkers Market, share:
Corporate email (business domain only)
Authentic phone number with country code
Specific data requirements
Examples: "AI-driven cardiac biomarker landscape," "neurology validation pipeline," "APAC digital biomarker market sizing."
You'll receive a precise, customized preview of the full 477-page Digital Biomarkers Market Report.
Get a preview of our Digital Biomarkers Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/digital-biomarkers-market-78664
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Biomarkers Market | 68% hardware dominance, 24.5% CAGR and the companies rewriting clinical measurement here
News-ID: 4276142 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
APAC Deepfake Detection Market Accelerates as Governments Tighten Digital Trust …
A Market Transforming How the World Verifies Reality
The global deepfake detection technology market, valued at USD 0.6 billion in 2025, is positioned to accelerate at a powerful 37.2% CAGR, reaching USD 15.1 billion by 2035.
This growth is driven by one undeniable truth:
Synthetic media is reshaping the threat landscape faster than humans can recognize it.
Deepfake detection technologies now determine:
How newsrooms verify breaking content
How financial institutions prevent identity-spoofing
How governments protect election integrity
How…
Travel & Expense Management Software Market Signals a Digital Pivot | AI, Cloud …
The Travel and Expense Management (TEM) Market Crossroads | A Sector Accelerating, Repricing Efficiency, and Redrawing the Corporate Spend Map
(Is TEM a Back-Office Tool-or the Operating System of the Next Enterprise Economy?)
For years, the travel and expense management software market lived in the administrative shadows-handed off to finance teams, constrained by spreadsheets, and dismissed as a routine cost-control tool. But the numbers now tell a radically different story.
In 2025, the…
Oilfield Equipment Market hits USD 116.2B in 2025 and grows to USD 156.5B by 203 …
Oilfield Equipment Market | The $156.5B Hardware Backbone of the Global Energy System
Every headline loves clean energy. Yet the global energy mix still demands a brutal truth: oil and gas remain the world's primary supply of heat, mobility, and petrochemicals - and the machines that drill, lift, complete, and produce hydrocarbons continue to define industrial capability.
That's why the Oilfield Equipment Market remains a strategic industry - not a relic.
In 2025,…
Machine Tools Market 2025-2035 | USD 109.9B Growth, CNC & Automation Trends
Machine Tools Market | The $109.9B Intelligence Engine of Global Manufacturing
Factories don't work without machine tools. They shape, cut, drill, grind, and define the physical world around us. Yet most end-products - cars, aircraft parts, electronics housings, surgical devices - never reveal the precision machinery behind them.
The Machine Tools Market is the invisible infrastructure that turns digital models into physical reality.
In 2025, the global Machine Tools Market stands at USD…
More Releases for Digital
Digital luxury brands Market Is Booming Worldwide | Major Giants Balenciaga Digi …
HTF MI recently introduced Global Digital luxury brands Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Digital luxury brands Market are:
Balenciaga Digital, Louis Vuitton Digital, Gucci Digital, Dolce & Gabbana DGFamily, Prada Virtual,…
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft.
In today's world, it can be tough for content creators and publishers to make money and connect with their audience.
At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction
The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031.
Industry Overview
Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect.
Get Sample Copy of this Report -…
